Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Konica Minolta ( (JP:4902) ) has shared an announcement.
Konica Minolta reported fiscal-year 2026 revenue of ¥1.09 trillion, down 3.6% year-on-year, but sharply improved profitability, with business contribution profit up 66.6% to ¥53.2 billion and a swing to operating profit of ¥49.9 billion. Profit attributable to owners reached ¥30.3 billion versus a ¥47.5 billion loss a year earlier, while equity attributable to owners rose to ¥536.5 billion and the equity ratio improved to 43.4%, indicating a stronger balance sheet following the classification of the Precision Medicine business as a discontinued operation.
Operating cash flow increased to ¥86.3 billion, supporting higher cash and cash equivalents of ¥110.8 billion at year-end despite negative investing and financing cash flows. The results suggest that restructuring efforts and portfolio shifts are stabilizing the company’s core businesses and improving financial resilience, which may reassure shareholders after the prior year’s losses and enhance Konica Minolta’s flexibility for future strategic investments and shareholder returns.
The most recent analyst rating on (JP:4902) stock is a Buy with a Yen700.00 price target. To see the full list of analyst forecasts on Konica Minolta stock, see the JP:4902 Stock Forecast page.
More about Konica Minolta
Konica Minolta, Inc. is a Japan-based technology company listed on the Tokyo Stock Exchange Prime Market. The company operates primarily in imaging, printing, and related digital solutions, serving corporate and institutional customers globally with office equipment, industrial systems, and various optical and IT-based services.
Average Trading Volume: 3,402,789
Technical Sentiment Signal: Sell
Current Market Cap: Yen271.5B
Find detailed analytics on 4902 stock on TipRanks’ Stock Analysis page.

